questionText: To ask the Secretary of State for Health and Social Care, what (a) guidance and (b) support his Department has made available to healthcare professionals on the management of patients impacted by pancreatic enzyme replacement therapy medications shortages
answerText: The Department is continuing to engage with all suppliers of pancreatic enzyme replacement therapy (PERT) to boost production to mitigate the supply issue. Through this work we have managed to secure additional volumes of PERT for 2025. The Department has...
heading: Pancreatic Enzyme Replacement Therapy: Drugs